Intellectual property law plays a crucial role in the pharmaceutical industry, providing a framework for innovation, incentivizing research and development, and ensuring the availability of life-saving medications. The patenting of drugs and the balance between innovation and access to medicines are key aspects within this context. Let's discuss the role of intellectual property law in the pharmaceutical industry and the delicate balance it seeks to strike:
1. Patenting of Drugs:
a. Incentivizing Innovation: Patents provide pharmaceutical companies with exclusive rights over their inventions, allowing them to recoup the significant investments made in research, development, and clinical trials. Patents incentivize innovation by granting a limited monopoly period, typically 20 years, during which competitors are prohibited from manufacturing or selling the same drug.
b. Patentable Subject Matter: To be eligible for a patent, a drug must meet the requirements of novelty, non-obviousness, and industrial applicability. Novelty ensures that the drug is not previously known or disclosed, while non-obviousness determines whether the drug's invention involves inventive steps beyond existing knowledge. Industrial applicability ensures that the drug has a specific practical application in the field of medicine.
c. Regulatory Cons....
Log in to view the answer
